Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Miconazole in systemic candidiasis.

H J Wüst1, H Lennartz

  • 1Department of Surgery, University Hospital of Düsseldorf, West Germany.

Proceedings of the Royal Society of Medicine
|January 1, 1977
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding the role of mammographers: a training strategy to enhance mammographer-patient interaction.

Breast disease·2005
Same author

ARDS in fulminant ornithosis and treatment with extracorporeal lung assist.

The International journal of artificial organs·2000
Same author

[Intra- and postoperative airway management of tracheal carina ruptures from bilateral endobronchial intubation].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·1999
Same author

[Rett's syndrome: pathophysiology and anesthesiological implications].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·1999
Same author

[Blood gas analysis in interhospital transfer--a useful extension of respiratory monitoring?].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·1999
Same author

Elimination of drugs by the new polyamide hemofilter FH77H during various in vitro conditions.

Blood purification·1998

Miconazole is recommended for systemic and pulmonary candidal infections, administered intravenously then orally. This antifungal is safe and effective, but not for prophylactic use in surgical patients.

Area of Science:

  • Mycology
  • Pharmacology

Background:

  • Systemic and pulmonary candidal infections pose significant risks, especially in surgical patients.
  • Effective antifungal agents are crucial for managing invasive candidiasis.

Observation:

  • Miconazole emerged as a preferred treatment based on initial patient experiences.
  • The drug demonstrated a favorable safety profile with no serious side effects noted.

Findings:

  • Intravenous miconazole is administered for 1-2 weeks post-negative culture, followed by 4 weeks of oral therapy.
  • Dosage is standardized at 1.2 g/day for a 70 kg patient.
  • A 1% incidence of candidal infections in surgical patients does not warrant prophylactic miconazole use.

Implications:

Related Experiment Videos

  • Miconazole offers a viable therapeutic option for invasive candidiasis.
  • Treatment should be guided by clinical manifestation and positive culture results, not prophylaxis.
  • Further research into optimal treatment durations and patient populations may be beneficial.